Showing results (171-180 of 214) with videos related to
Sort By:
Pageof 22
International Journal of Molecular Sciences|April 13, 2023
Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in Prostate Carcinoma CellsKang-Shuo Chang, Syue-Ting Chen, Hsin-Ching Sung, et al.Nanotechnology|December 11, 2012
Imaging layer number and stacking order through formulating Raman fingerprints obtained from hexagonal single crystals of few layer grapheneJih-Shang Hwang, Yu-Hsiang Lin, Jeong-Yuan Hwang, et al.Frontiers in Medicine|January 20, 2022
Prostate-Specific Antigen Velocity Predicts Surgical Outcome of Thulium Laser Enucleation of the ProstatePo-You Chen, Shao-Ming Chen, Horng-Heng Juang, et al.Journal of Cellular Physiology|November 12, 2024
Glucose Upregulates ChREBP via Phosphorylation of AKT and AMPK to Modulate MALT1 and WISP1 ExpressionSyue-Ting Chen, Kang-Shuo Chang, Yu-Hsiang Lin, et al.Biomedicines|April 3, 2021
Mucosa-Associated Lymphoid Tissue 1 Is an Oncogene Inducing Cell Proliferation, Invasion, and Tumor Growth via the Upregulation of NF-κB Activity in Human Prostate Carcinoma CellsKe-Hung Tsui, Kang-Shuo Chang, Hsin-Ching Sung, et al.International Journal of Molecular Sciences|October 14, 2022
WNT1 Inducible Signaling Pathway Protein 1 Is a Stroma-Specific Secreting Protein Inducing a Fibroblast Contraction and Carcinoma Cell Growth in the Human ProstateKang-Shuo Chang, Syue-Ting Chen, Hsin-Ching Sung, et al.European Journal of Gastroenterology & Hepatology|December 19, 2019
Add-on sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: a real-world experiencePo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 10, 2019
The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patientsPo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.American Journal of Cancer Research|April 9, 2024
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitorPo-Ting Lin, Yu-Chun Hsu, Yu-Ting Kao, et al.Urology|July 7, 2022
Incidental Tuberculosis Epididymitis/Epididymo-orchitis: A Retrospective Analysis at a Tertiary Center in TaiwanYu-Kuan Yang, Hsiao-Wen Chen, Li-Chueh Weng, et al.Pageof 22